Source: Journal of Cardiovascular Pharmacology. Unidade: FOB
Subjects: ANTI-INFLAMATÓRIOS, HORMÔNIOS GLICOCORTICOIDES, PRESSÃO SANGUÍNEA, MIOCÁRDIO, MICRORNAS, EXERCÍCIO FÍSICO
ABNT
HERRERA, Naiara A. et al. Dexamethasone does not inhibit treadmill training–induced angiogenesis in myocardium: role of MicroRNA-126 pathway. Journal of Cardiovascular Pharmacology, v. 76, n. 6, p. 708-714, 2020Tradução . . Disponível em: https://doi.org/10.1097/FJC.0000000000000924. Acesso em: 18 nov. 2024.APA
Herrera, N. A., Duchatsch, F., Tardelli, L. P., Dionisio, T. J., Santos, C. F. dos, & Amaral, S. L. do. (2020). Dexamethasone does not inhibit treadmill training–induced angiogenesis in myocardium: role of MicroRNA-126 pathway. Journal of Cardiovascular Pharmacology, 76( 6), 708-714. doi:10.1097/FJC.0000000000000924NLM
Herrera NA, Duchatsch F, Tardelli LP, Dionisio TJ, Santos CF dos, Amaral SL do. Dexamethasone does not inhibit treadmill training–induced angiogenesis in myocardium: role of MicroRNA-126 pathway [Internet]. Journal of Cardiovascular Pharmacology. 2020 ; 76( 6): 708-714.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1097/FJC.0000000000000924Vancouver
Herrera NA, Duchatsch F, Tardelli LP, Dionisio TJ, Santos CF dos, Amaral SL do. Dexamethasone does not inhibit treadmill training–induced angiogenesis in myocardium: role of MicroRNA-126 pathway [Internet]. Journal of Cardiovascular Pharmacology. 2020 ; 76( 6): 708-714.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1097/FJC.0000000000000924